
|
|  | |
|
Am J Psychiatry 1990; 147:1138-1148
Copyright © 1990 by American Psychiatric Association
Continuous versus targeted medication in schizophrenic outpatients: outcome results [published erratum appears in Am J Psychiatry 1991 Jun;148(6):819]
WT Carpenter Jr, TE Hanlon, DW Heinrichs, AT Summerfelt, B Kirkpatrick, J Levine and RW Buchanan
Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore 21228.
The authors report on the outcome of treatment of 116 outpatients with
chronic schizophrenia who were assigned to a 2-year, single-blind course of
treatment with either targeted or continuous medication. These patients
were not restricted to those who were good candidates for a medication
reduction strategy. Continuous medication was superior to targeted
medication in preventing decompensations and hospitalizations and in extent
of employment at 2 years. Other measures of psychopathology and functioning
at 1 and 2 years did not differentiate the two groups of patients. The
targeted approach achieved a substantial reduction in total medication
through a reduction in the number of days of medication administration.
This article has been cited by other articles:

|
 |

|
 |
 
M. S Turner and D. W Stewart
Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
J Psychopharmacol,
November 1, 2006;
20(6 Suppl):
20 - 37.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Keith, L. Pani, B. Nick, R. Emsley, L. San, M. Turner, R. Conley, P. Scully, P. S. Chue, and B. Lachaux
Practical Application of Pharmacotherapy With Long-Acting Risperidone for Patients With Schizophrenia
Psychiatr Serv,
September 1, 2004;
55(9):
997 - 1005.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gitlin, K. Nuechterlein, K. L. Subotnik, J. Ventura, J. Mintz, D. L. Fogelson, G. Bartzokis, and M. Aravagiri
Clinical Outcome Following Neuroleptic Discontinuation in Patients With Remitted Recent-Onset Schizophrenia
Focus,
January 1, 2004;
2(1):
122 - 130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. R. Schooler
Maintenance Medication for Schizophrenia: Strategies for Dose Reduction
Focus,
January 1, 2004;
2(1):
175 - 186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. O'Ceallaigh and T. Fahy
Is there a role for the depot clinic in the modern management of schizophrenia?
Psychiatr. Bull.,
December 1, 2001;
25(12):
481 - 484.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gitlin, K. Nuechterlein, K. L. Subotnik, J. Ventura, J. Mintz, D. L. Fogelson, G. Bartzokis, and M. Aravagiri
Clinical Outcome Following Neuroleptic Discontinuation in Patients With Remitted Recent-Onset Schizophrenia
Am J Psychiatry,
November 1, 2001;
158(11):
1835 - 1842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Birchwood, E. Spencer, and D. McGovern
Schizophrenia: early warning signs
Advan. Psychiatr. Treat.,
March 1, 2000;
6(2):
93 - 101.
[Full Text]
|
 |
|

|
 |

|
 |
 
M. I. Herz, J. S. Lamberti, J. Mintz, R. Scott, S. P. O'Dell, L. McCartan, and G. Nix
A Program for Relapse Prevention in Schizophrenia: A Controlled Study
Arch Gen Psychiatry,
March 1, 2000;
57(3):
277 - 283.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. T. Carpenter Jr., R. W. Buchanan, B. Kirkpatrick, H. D. Lann, A. F. Breier, and A. T. Summerfelt
Comparative Effectiveness of Fluphenazine Decanoate Injections Every 2 Weeks Versus Every 6 Weeks
Am J Psychiatry,
March 1, 1999;
156(3):
412 - 418.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
W. T. Carpenter Jr., R. W. Buchanan, B. Kirkpatrick, and A. F. Breier
Diazepam Treatment of Early Signs of Exacerbation in Schizophrenia
Am J Psychiatry,
February 1, 1999;
156(2):
299 - 303.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. M. Kane
Schizophrenia
N. Engl. J. Med.,
January 4, 1996;
334(1):
34 - 42.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. T. Carpenter and R. W. Buchanan
Schizophrenia
N. Engl. J. Med.,
March 10, 1994;
330(10):
681 - 690.
[Full Text]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 1990
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|